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ABSTRACT
Int J Exerc Sci 5(1) : 50-59, 2012. Caffeine is thought to provide ergogenic benefits during
endurance performance. However, there is limited research on the effects of caffeine on anaerobic
sports performance. The purpose of this study was to examine the effects of 6 mg·kg-1 of caffeine
on repeated sprint performance. The sample included active college students (N = 18), classified
as habitual caffeine or caffeine naïve users. Participants completed a 12 x 30-m sprint test with 35
s rest intervals between sprints. Ratings of Perceived Exertion were collected every 3rd sprint.
Height and body mass were measured and participants accommodated to the sprint test on Day
1. Participants were randomly assigned to the placebo or caffeine condition on Day 2 and the
treatment was reversed on Day 3. Caffeine was ingested in a sports drink 1 h prior to performing
the sprints. Caffeine produced a significantly faster best sprint time compared to the placebo trial,
F (1, 17) = 7.38, MSE = .02, H-F p = .02. However, no significant difference was found between
caffeine supplementation and placebo on time to complete the total sprint test. Additionally, no
significant difference was found in sprint times with caffeine supplementation by sex or between
caffeine-naïve and habitual caffeine users. Finally, a significantly higher average RPE was found
with caffeine supplementation as compared to the placebo, t (1, 17) = 2.92, d = .38, p = .01.
Caffeine has the potential to enhance sprint performance however, further research with women
and habitual caffeine consumers is needed.
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INTRODUCTION
Caffeine is one of the most frequently
consumed drugs in the world, and has
minimal health risks (18). It is found in
numerous foods including chocolate and
beverages, with coffee, tea, and soft drinks
being consumed most frequently (16).

Caffeine is also found in some over-thecounter medications and energy drinks.
Caffeine is quickly absorbed with plasma
levels reaching a maximum level within 1 h
of ingestion (18). Caffeine is slowly
catabolized with a half-life or time to
decrease its initial quantity by one half, of 4
to 6 h (18). Factors such as oral
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contraceptive use and smoking may affect
the half-life of caffeine (1, 7, 23). Caffeine is
catabolized by the cytochrome P450 system
in the liver to three dimethylxanthines:
paraxanthine,
theophylline,
and
theobromine, which are then further
catabolized (18).

banned substance list in 2004 (26) and the
National Collegiate Athletic Association
(NCAA) setting a high urinary level of 15
g/mL for a positive test (21), the door has
now been opened for further investigation
on the effects of caffeine on sports
performance.
Since
1978,
numerous
researchers have investigated caffeine’s
possible ergogenic effects on endurance
capacity (4, 5, 6, 9, 13, 15). While many of
the earlier studies provided mixed results,
more recent studies clearly show that
caffeine has the possibility to be ergogenic
for both long-term and short-term
endurance performance (4, 5, 6, 9, 13, 15),
although the degree of its effects may
depend on the characteristics of the users,
such as level of training (12) and habitual
use of caffeine (4).

The details of how caffeine provides
ergogenic aid to sports performance remain
unclear, although several explanations have
been proposed. Costill and colleagues
proposed an increased use of fat as fuel for
exercise thus sparing liver and muscle
glycogen (13). An increased reliance on
lipolysis
benefits
performance
by
conserving liver and muscle glycogen
leading to delayed muscle fatigue.
However, this mechanism may only be
beneficial for endurance sports because the
oxidative energy system is not dominant
during anaerobic activities such as
sprinting.

Researchers have also investigated the
effect of caffeine on anaerobic performance.
Collomp et al. (11), Greer et al. (19), and
Bell et al. (3) all failed to show
improvement from caffeine in a Wingate
testing protocol. While Wingate testing is
purported to be a test of anaerobic power, it
may be impractical for sports that involve
multiple bouts of high intensity work.
Repeated sprints are found in numerous
sports including track, American football,
basketball, and soccer. Because these sports
have maximal or near maximal sprints
accompanied by brief periods of rest or low
intensity running, caffeine may be
beneficial in these sports due to the mixed
aerobic and anaerobic components.

Another possible mechanism for caffeine’s
ergogenic effect during exercise is its effect
on the central nervous system (CNS).
Because of caffeine’s lipid solubility, it is
able to cross the blood-brain barrier (20)
and act as an adenosine antagonist (14). The
receptors that are most likely affected by
caffeine are the A1 and A2A receptors (16).
Caffeine’s ability to act as an adenosine
blockade in the CNS appears to be the most
promising mechanism of action. While the
mechanism of how caffeine may provide
ergogenic aid remains debatable, much
research has been conducted to test
caffeine’s
effects
during
sports
performance.

Collomp et al. (12) found that specific
training may be needed to see an effect
from a 250 mg caffeine supplementation.
These researchers concluded that intraand/or extra-cellular adaptions that result

With the World Anti-Doping Agency
(WADA) removing caffeine from the
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from specific training are necessary to
benefit from caffeine during sprint
performance. One potential issue with their
study was the use of an absolute dosage of
caffeine as opposed to a relative to body
mass dosage. This may have provided
smaller individuals with a greater effect
and larger individuals with less of an effect
from the caffeine.

(16). Some researchers have attempted to
address if differences exist in the
effectiveness of a caffeine supplement on
sports performance in those with habitual
caffeine use compared to those consuming
small amounts of caffeine. Dodd et al. (15)
found no effect on VO2 max or anaerobic
threshold from a caffeine supplement of 5
mg·kg-1 in habitual and caffeine naïve
participants. While resting metabolism and
ventilation, as well as resting and exercise
plasma free fatty acid (FFA) increased in
the caffeine naïve group, this did not affect
performance outcomes (15). However, Bell
et al. (4) found that differences did exist
between habitual and caffeine naïve users.
Using a 5 mg·kg-1 body mass caffeine
supplement and 6 exercise rides to
exhaustion, the results indicated that the
ergogenic effect was greater in nonusers,
resulting in increased time to exhaustion.
Controversy still exists if habitual use of
caffeine will lead to decreased effectiveness
of a caffeine supplement on sports
performance.

Both Stuart et al. (25) and Schneiker et al.
(24) found improved performance from
tests designed to mimic the demands of
various sports. Both studies used 6 mg·kg-1
of caffeine and found improvements in
performance while caffeine levels remained
below a positive drug test according to
NCAA policy (24, 25). Glaister et al. (17)
and Carr et al. (10) also found improved
sprint performance from both 5 mg·kg-1 and
6 mg·kg-1 of caffeine. Participants in both
studies were active individuals however,
the studies included only male participants.
While there are relatively few studies to
investigate caffeine supplementation in a
repeated sprint testing protocol, the lack of
female participants is a recurring theme (10,
17, 22, 24, 25).

Therefore, the purpose of this study was to
examine the effects of ingesting 6 mg·kg -1
body mass of caffeine on performance in a
multiple sprint running ability test with
male and female participants who were
either habitual caffeine consumers or
caffeine naïve. It was hypothesized that
caffeine ingestion would significantly
decrease the time to complete the fastest
individual sprint and total time to complete
the repeated sprint protocol as compared to
the fastest placebo trial and total time and
that habitual caffeine users would see less
improvement in fastest individual sprint
times than caffeine naïve participants.
Additionally, it was hypothesized that
there would be no significant sex difference

Paton et al. (22) however, found caffeine
supplementation to not be beneficial in
team sport athletes. This study did include
a relative to body mass dosage, however
the testing protocol may not have allowed
enough rest time between sprints. The
testing protocol consisted of 10 sprints each
of 20 m in distance. Each sprint was
required to be performed in 10 s with the
remainder of that time for rest.
The ability to develop tolerance to caffeine
effects is well known (16). There is an
increase in the number of adenosine A1
receptors following long-term caffeine use
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in the effect of caffeine on sprint times
(individual sprint times and total time to
complete test procedure). Finally, it was
hypothesized that average rating of
perceived exertion (RPE) recorded during
the repeated sprint testing protocol would
be significantly lower in the caffeine trial as
compared to the placebo trial.

exercise habits (including the types of
exercise and for how long they participated
in these activities), smoking habits, and
lastly, caffeine usage. An attempt to include
all forms of caffeine was made on this
questionnaire which included soft drinks,
as well as other drinks including, but not
limited to, coffee, foods such as chocolate
candy bars, over-the-counter medication,
and prescription medications. Participants
were asked to report use of the products on
an “average” day’s use.

METHODS
Participants
The participants included 18 active college
students from the southeastern United
States who were classified as caffeine naïve
(6 males, 4 females) or habitual caffeine
users (3 males, 5 females) based on a
questionnaire created by the principal
investigator. Most of the participants in the
study were undergraduate exercise science
majors. Three of the participants were
NCAA Division I collegiate athletes playing
basketball (n = 1) or softball (n = 2). Most
participants had a history of sports
participation in a variety of sports. None of
the participants were smokers and all of the
female participants but two were taking
oral
contraception.
Demographic
characteristics are presented in Table 1.
Participants gave their verbal and written
informed consent to participate in the study
that was approved by the University
Institutional Review Board.

Table 1. Demographics for the Sample (N = 18) and
Female (n = 9) and Male (n = 9) Participants

Note. BMI = body mass index.

The second questionnaire was the Physical
Activity Readiness Questionnaire (PAR-Q).
To qualify for participation, participants
had to be active (defined as engaging in at
least 3.5 h per week of exercise), a nonsmoker, caffeine naïve (defined as
consuming less than 50 mg · day -1 or less)
or habitual caffeine user (defined as
consuming equal to or greater than 300 mg
· day -1), not taking medication for
ADD/ADHD, and finally have no health
issues as determined by the PAR-Q. Terms
to define habitual and caffeine naïve were
similar to those previously defined by Bell
et al. (4). Of the volunteers who met the

Experimental design
Volunteers for the study first completed
questionnaires, without knowledge of the
study
purpose,
to
assess
their
qualifications. The first questionnaire
included questions on age, sex, Attention
Deficit
Disorder/Attention
Deficit
Hyperactivity Disorder (ADD/ADHD),
contraceptive usage for female participants,
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study requirements, 11 females (6 habitual
caffeine users and 5 caffeine naïve) along
with 11 males (5 habitual caffeine users and
6 caffeine naïve) were selected to complete
this study.

Using a within-subjects experimental
design, participants received either caffeine
(6 mg·kg-1 body mass; Sigma Aldrich)
mixed in a sports drink or a placebo (plain
sports drink) 1 h prior to testing. All
dosages were above all the participants’
normal caffeine consumption (caffeine
naïve M = 27.66 mg, habitual caffeine M =
314.80 mg). The treatment (caffeine or
placebo) was distributed with participants
blind to the condition (prescribed caffeine
M = 425.57 mg). Assignment to the
treatment condition was conducted in a
randomized and counterbalanced manner.
The treatment was reversed during day 3
for each participant for the counterbalanced
experimental design. During all testing
sessions, RPE, Borg scale 6 – 20 (8), was
collected from the participants’ every third
sprint.
Participants
were
equally
encouraged and motivated to give their
best effort before and throughout each
testing session. Timing of the sprints was
recorded electronically using a twin-beam
photocell timing gate system (Brower
Timing System; Draper, UT).

During day 1, the participants’ height and
body mass were recorded. Body mass (to
the nearest 0.1 kg) was measured via a scale
(SECA; Hanover, MD) with the participants
dressed in shorts and a shirt and the
caffeine dosage was calculated from this
measurement. Height was measured with a
stadiometer (SECA; Hanover, MD) to the
nearest 0.1 cm. Participants were asked to
remove their shoes for both measurements.
Using height and body mass, the BMI of
each participant was calculated. Day 1 was
also used to familiarize the participants
with the testing protocol. After day 1, 4
participants (2 habitual caffeine males, 1
habitual caffeine female, and 1 caffeine
naïve female) decided to withdraw from
the study due to scheduling conflicts with
coaches or injury.
Participants were given 3 days notice prior
to days 2 and 3 and, consistent with
previous literature (3, 6, 15), were asked to
refrain from caffeine usage (all food,
prescription medication, and beverages)
and vigorous exercise 24 h prior to testing
(3, 6, 15). This served as the washout period
for previous caffeine usage to assure equal
dosing. Participants were allowed to
maintain their normal diet but were asked
to avoid consumption of food or beverage
(with the exception of the test drink) within
1 h of testing. All testing occurred within a
2 week time period with day 1 occurring
during week 1 and experimental days 2 and
3 occurring during week 2 with 48 h of rest
between trials.
International Journal of Exercise Science

Before testing began on days 2 and 3,
participants completed a standard warmup consisting of 1 lap of jogging (selfselected pace) around the University’s
indoor track, ad libitum stretching, and a 1
x 30 m sprint. Using a similar testing
protocol to Glaister et al. (17), participants
individually completed a repeated sprint
test (12 x 30-m; repeated at 35 s intervals).
Sprints were performed in opposite
directions to maximize the 35 s recovery
time between sprints. Participants were
instructed to stand behind the starting line
to prevent premature triggering of the
timing gates and were given a verbal 5 s
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countdown prior to each sprint. Each sprint
began with the participants in an athletic
stance with their non-dominant foot
forward.

found on the time to complete the total
sprint test for the full sample F1, 17 = 3.94,
MSE = 1.47, P = .06. While all mean sprint
times were faster with caffeine, only sprints
3 and 5 reached the level of significance (see
Table 2). Further, no significant sex
difference was found in total time to
complete the sprint test as well as
individual sprint times with caffeine
supplementation as compared to without
caffeine supplementation (see Table 3). No
significant difference was found between
caffeine naïve (M = .08 s, SD = .14 s, n = 10)
and habitual caffeine users (M = .17 s, SD =
.24 s, n = 8) in the difference score of the
fastest individual sprint times, t 1, 16 = -1.01,
d = -.46, P = .33. Finally, a significantly
higher average RPE was found with
caffeine supplementation as compared to
the placebo trial t 1, 17 = 2.92, d = .38, P = .01
(See Table 2).

Statistical analysis
The Statistical Package for the Social
Sciences for Windows (SPSS Inc., Chicago,
IL, Version 17.0) was used for statistical
analyses. A repeated-measure analysis of
variance (RMANOVA) was utilized to test
the differences in the fastest sprint times
and total time to complete the sprint test
between the caffeine and placebo trials. An
independent t-test was utilized to test the
difference between the sexes and between
caffeine naïve and habitual caffeine use on
sprint times and total time to complete the
sprint test. A difference score was created
by subtracting the caffeine trial from the
placebo trial for both the total time and
individual sprints. Finally, a paired t-test
was used to analyze average RPE from the
caffeine and placebo trials. Average RPE
was calculated by averaging the RPE of
sprints 3, 6, 9, and 12. Cohen’s d was used
to calculate effect sizes. The method of
Cohen’s d used was (M1 – M2/ pooled SD).
Pooled SD was calculated with the formula
[(SD1 + SD2)/2]. The statistical significance
was set at an alpha level of .05 for all
analyses.

Table 2. Sprint Times (s) and RPE for the Full
Sample (N = 18)

RESULTS
There was a significant difference between
caffeine supplementation and placebo on
the fastest individual sprint time for the full
sample F1, 17 = 7.38, MSE = .02, P = .02.
However, no significant difference between
caffeine supplementation and placebo was

International Journal of Exercise Science

Note. Values presented as mean ± standard
deviation; RPE = Rating of perceived exertion; * P <
.05; ** P = .01
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Table 3. Difference in Sprint Times (s) Caffeine
Supplement vs. Placebo by Sex

other studies showing no improvement (11,
15, 19, 22). However, while the mean times
with caffeine were faster for all sprints, only
sprints 3 and 5 reached statistical
significance. The lack of statistical
significance on all sprints may have been
due to the small sample size. The mean
sprint times and effect sizes all indicate a
decrease with the caffeine supplement that
may reach significance with a larger sample
size. While only two sprints reached the
level of significance, the practical results
show that caffeine has the potential to
improve sports performance with sports
that include multiple sprints.

Note. Values presented as mean ± standard deviation

No significant difference was found in the
fastest individual sprint times with caffeine
ingestion between caffeine naïve and
habitual caffeine consuming participants.
Therefore, the hypothesis that habitual
caffeine consumers would see less of a
reduction in the fastest individual sprint
times with caffeine ingestion compared to
caffeine naïve participants was not
supported. The reason for the hypothesis
that habitual caffeine users would see less
of a benefit from caffeine was the
physiological adaptations that occur with
regular caffeine usage. It has been
suggested that those who consume caffeine
on a long-term basis build-up additional
adenosine receptors (18) and therefore it
may take more caffeine for the same effect
in this group. The results of this study
indicate that habitual caffeine usage
potentially has no detrimental effect on
caffeine’s ergogenic effect in a sprint test
protocol.

DISCUSSION
The purpose of this study was to test the
effect of 6-mg·kg -1 body mass of caffeine on
multiple sprint running performance in
active male and female participants who
were either habitual caffeine consumers or
caffeine naïve. Glaister et al. (17) was the
model for this study. However, this study
included both male and female participants
and also examined the effect of the
supplement on habitual and caffeine naïve
users.
Caffeine ingestion produced a significant
improvement in the fastest individual
sprint as compared to the non-caffeine
sprint trial. Consequently, the hypothesis
that caffeine ingestion would significantly
decrease the time to complete the fastest
individual sprint was supported. This
finding supports the results of previous
studies showing improved performance
with caffeine supplementation (2, 3, 4, 5, 9,
10, 12, 13, 17, 24, 25) and contrasts with

International Journal of Exercise Science

Similar terms were used to define caffeine
usage in the current study and the study by
Bell et al. (4) that also included male and

56

http://www.intjexersci.com

CAFFEINE AND SPRINT PERFORMANCE
female participants. However, the finding
in this study contradicts the finding of Bell
et al. (4) who indicated nonusers received a
greater
benefit
from
caffeine
supplementation. The key difference
between the studies was the testing
protocols with the present study being
anaerobic in nature and that of Bell et al. (4)
being an aerobic protocol. However, Dodd
et al. (15) also found no significant
difference between male habitual caffeine
users and caffeine naïve users. These
authors (15) defined caffeine usage in a
similar manner to the present study.

heart rate, the mean increase in heart rate
was 3.4 bpm. A review article by
Freedholm et al. (16) also indicated that
high caffeine intake produces tachycardia.
Glaister et al. (17) also reported increased
blood lactate concentrations both pre-and
post-testing with caffeine. Other studies
have also reported increases in blood
lactate levels with caffeine supplementation
(2, 3, 10, 11). Although heart rate and lactate
measures were not taken in this present
study, if caffeine produced these same
effects, this may be a reason for the
increased RPE. Glaister et al. (17) also
mentioned
that
increases
in
RPE
corresponded with increases (decrement) in
sprint time and heart rate, which indicates
the validity of the RPE scale for a sprint
testing protocol.

The change in performance in individual
and total sprint times in response to
caffeine was not different in males and
females. Thus, the hypothesis that that
there would be no significant sex difference
in the effect of caffeine on sprint times
(individual sprint times and total time to
complete test procedure) was supported.
While this study found no sex differences
with the supplement, more research studies
are needed comparing sexes.

It is also important to note that while RPE
was
statistically
different
between
conditions, the difference may not be
practically significant. Because RPE is
reported as a whole number, both the
average RPE with and without caffeine was
13. This shows that while it was statistically
significant, it was not different in a practical
sense.

The average RPE for every third sprint was
found to be significantly higher with
caffeine than without caffeine. Therefore,
the hypothesis that average rating of
perceived exertion (RPE) recorded during
the repeated sprint testing protocol would
be significantly lower in the caffeine trial as
compared to the placebo was not
supported. This is an interesting finding
because it is the opposite of traditional
thought and previous research that
indicates that caffeine lowers RPE (13).
Glaister et al. (17), using the same testing
protocol as this study, found no significant
difference in RPE. In the study by Glaister
et al. (17), which included measures of
International Journal of Exercise Science

The strengths of the current study are the
inclusion of female participants and both
habitual and caffeine naïve users. The
inclusion of female participants is lacking in
the current literature testing caffeine’s
ergogenic effects (10, 17, 22, 24, 25). Few
studies have evaluated the effects of
caffeine supplementation on habitual and
caffeine naïve users, (4, 15) and this is the
first to date to evaluate the effects of
habitual caffeine usage on a caffeine
supplement in a sprint testing protocol.
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This study also has limitations. One
limitation of this study is the small
heterogeneous sample size that included
both collegiate athletes and recreationally
active participants. The study by Collomp
et al. (12) indicates that specific training
may be needed to see a benefit from
caffeine and the mixed sample may have
produced mixed results. This is unlikely
however because only 3 of the 18
participants were collegiate athletes.
Another limitation of this study was the
absence of heart rate and blood lactate
measurements. Based on previous findings
it is likely that both blood lactate and heart
rate
increased
with
the
caffeine
supplement.

making it difficult to detect any difference
due to oral contraceptive use.
In conclusion, the results of this study
indicate that caffeine supplementation
using 6 mg·kg-1 body mass does improve
sprint performance. Furthermore, the
results indicate that habitual caffeine use
did not cause decreased effectiveness of the
caffeine supplement and the effect did not
vary by sex. Overall, this study shows that
caffeine does have the potential to improve
sprint performance and may be beneficial
to sports that incorporate sprinting.
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